Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000662971 | SCV000785951 | uncertain significance | Lynch syndrome 5 | 2018-01-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001868184 | SCV002168851 | uncertain significance | Hereditary nonpolyposis colorectal neoplasms | 2023-10-07 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 2 of the MSH6 gene. It does not directly change the encoded amino acid sequence of the MSH6 protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MSH6-related conditions. ClinVar contains an entry for this variant (Variation ID: 548843). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Myriad Genetics, |
RCV000662971 | SCV004018447 | uncertain significance | Lynch syndrome 5 | 2023-03-27 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |